BioCT 2023 Legislative Agenda – Revised

As the voice for the bioscience industry in Connecticut, BioCT’s works to provide education and advocacy for Connecticut’s bioscience and life science communities at the policy level and ensure synergy of action and alignment of state and federal initiatives that have a significant impact on our members.To view the 2023 Legislative Agenda, please click here.

Our Government Affairs Committee is comprised of BioCT board members, industry executives and business advisors including the government relations firm of Rome, Smith & Lutz, which has deep expertise in matters impacting our industry. Committee membership includes:
Dawn Hocevar
President & CEO, BioCT
Joni Arvai
Senior Manager, State Government Affairs, Bristol Myers Squibb
Kathy Andrews Bilotas
Director of State Government Affairs, Eli Lilly
Bill Claffey
Partner, Tax Services, Fiondella, Milone & LaSaracina
Sean Cassidy
Chief Financial Officer, Arvinas
Jennifer Herz
State Government Affairs, Regional Director, Boehringer Ingelheim
Ken Hiscoe
Director, US Government Relations/Corporate Affairs, Pfizer
Jillian Jackson
Associate Director of State Relations, Yale University
Kathryn Lavriha
Director, State Government Relations, Sanofi

Katherine Lutz
Partner, Rome, Smith & Lutz

Matthew O’Donnell
Senior Director, State Government Affairs, Alexion

Joseph Oros
Regional Director, State Government Affairs, AbbVie

Marie DeSanto
Schweitzer Director, Government Relations for Health Affairs, University of Connecticut

Dmitri Siegel
Director, Alliance Development, Bristol Myers Squibb

Christopher Smith
Vice President, Rome Smith & Lutz

Karla White
State Government Affairs Manager, East Coast, CSL Behring